This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Daxas
  • /
  • Roflumilast in Chronic Obstructive Pulmonary Disea...
Clinical trial

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting ?2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) (REACT)

Read time: 2 mins
Last updated:1st May 2011
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest